Theodore Wun, MD, FACP | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
healthcare providers

Theodore Wun, MD, FACP

Healthcare Provider
Chief, Division of Hematology and Oncology
School of Medicine, UC Davis Health
2279 45th Street
Sacramento, California, United States

Dr. Wun graduated from the Albany Medical College in 1984. He works in Sacramento, CA and 1 other location and specializes in Hematology/Oncology. Dr. Wun is affiliated with UC Davis Medical Center.

Ted Wun’s clinical interests are malignant and non-malignant hematology and he maintains an active clinical practice. His primary areas of research have been in the pathophysiology and complications of sickle cell disease (SCD) and the epidemiology of venous thromboembolism with focus on cancer-associated thrombosis.

He and his colleagues demonstrated significant platelet and leukocyte activation in SCD and described platelet-erythrocyte aggregates in these patients. He has participated in several multi-center therapeutic trials in SCD and is the former Chair of the Sickle Cell Disease Advisory Committee of the National Heart, Lung, and Blood Institute.


Representative Publications:

Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality

Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)

expertly curated content related to this topic